Samsung Biologics (207940:KS) PT Lowered to KRW1,140,000 at Credit Suisse
Tweet
Share
E-mailGet Alerts 207940:KS Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 13
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 9 | New: 13
Join SI Premium – FREE
Credit Suisse analyst Ray Kim lowered the price target on Samsung Biologics (207940:KS) to KRW1,140,000.00 (from KRW1,180,000.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Partners Group Holding AG (PGHN:SW) (PGPHF) PT Lowered to CHF1,060 at Goldman Sachs
- New Hope Corp (NHC:AU) (NHPEF) PT Lowered to AUD3.70 at Goldman Sachs
- Kingfisher Plc. (KGF:LN) (KGFHY) PT Raised to GBP3.20 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
